Chimerix Inc (NASDAQ:CMRX)
| 1.66 Delayed Data As of May 16 |  -2.58 / -60.85%Today’s Change | 1.60 Today|||52-Week Range 9.29 | -74.18% Year-to-Date |
Latest CMRX News | Press Releases
| Chimerix (CMRX) Q1 2022 Earnings Call Transcript May 16 / MotleyFool.com - Paid Partner Content | JetBlue Goes Hostile on Spirit, but This Biopharma's Getting Hit Hard May 16 / MotleyFool.com - Paid Partner Content |
| Here's Why Chimerix Stock Is Imploding Today May 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.24 |
| Today’s open | 1.94 |
| Day’s range | 1.60 - 1.99 |
| Volume | 37,953,416 |
| Average volume (3 months) | 1,468,419 |
| Market cap | $369.9M |
Data as of 05/16/2022
Growth & Valuation
| Earnings growth (last year) | -191.43% |
| Earnings growth (this year) | +92.32% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -63.16% |
| P/E ratio | -- |
| Price/Sales | 275.95 |
| Price/Book | 5.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRDNViridian Therapeutic... | -0.22 | -1.63% |
| ---- | ||
| ESPREsperion Therapeutic... | +0.11 | +1.90% |
| --Cassiopea SpA | 0.00 | 0.00% |
Data as of 05/16/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $2.0M |
| Annual profit (last year) | -$173.2M |
| Net profit margin | -8,753.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
Chart unavailable
